glucagon has been researched along with tiletamine hydrochloride in 1 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (tiletamine hydrochloride) | Trials (tiletamine hydrochloride) | Recent Studies (post-2010) (tiletamine hydrochloride) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 2,819 | 12 | 1,228 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreani, T; Belani, J; Bradley, P; Cao, Y; Chen, P; Cox, K; Dai, P; Dai, X; DeMong, D; Feng, KI; Gauuan, J; Greenlee, W; Grotz, D; Hwa, J; Kang, L; Kozlowski, J; Lachowicz, J; Lavey, B; Liang, M; Lin, P; Lin, SI; McNamara, P; Meng, T; Miller, M; Morrison, R; Patel, B; Sondey, C; Soriano, A; Stamford, A; Wong, J; Wong, M; Yang, DY; Yu, W; Zhai, Y; Zhang, H; Zhao, H; Zhou, G | 1 |
1 other study(ies) available for glucagon and tiletamine hydrochloride
| Article | Year |
|---|---|
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist.
Topics: Animals; Benzamides; Blood Glucose; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Discovery; Glucagon; Mice; Mice, Inbred ICR; Obesity; Prediabetic State; Receptors, Glucagon; Spiro Compounds; Structure-Activity Relationship | 2014 |